X-154413249-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000116.5(TAFAZZIN):c.281G>T(p.Arg94Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 24)
Consequence
TAFAZZIN
NM_000116.5 missense
NM_000116.5 missense
Scores
13
3
1
Clinical Significance
Conservation
PhyloP100: 7.11
Genes affected
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a chain Tafazzin (size 261) in uniprot entity TAZ_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_000116.5
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.984
PP5
Variant X-154413249-G-T is Pathogenic according to our data. Variant chrX-154413249-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 403954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAFAZZIN | NM_000116.5 | c.281G>T | p.Arg94Leu | missense_variant | 3/11 | ENST00000601016.6 | NP_000107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAFAZZIN | ENST00000601016.6 | c.281G>T | p.Arg94Leu | missense_variant | 3/11 | 1 | NM_000116.5 | ENSP00000469981.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
3-Methylglutaconic aciduria type 2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Lab, Nemours Children's Health, Delaware | Jul 08, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 28, 2018 | This variant has been observed to be de novo in an individual with cardiomyopathy (Invitae). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. Two different missense substitution at this codon (p.Arg94His and p.Arg94Ser) have been determined to be pathogenic (PMID: 23656970, 16548007, 12032589, 23656970). This suggests that the arginine residue is critical for TAZ protein function and that other missense substitutions at this position may also be pathogenic. Furthermore, two additional variants of uncertain significance at this codon (p.Arg94Gly and p.Arg94Cys) have been observed in individuals with Barth syndrome (PMID: 20812380, 9345098). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with leucine at codon 94 of the TAZ protein (p.Arg94Leu). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and leucine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;.;.;.;.;D;.;D
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;D;.;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;M;M;.;M;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D;.;.;.;D;D
REVEL
Pathogenic
Sift
Pathogenic
.;.;D;.;.;.;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D
Polyphen
0.99, 1.0, 1.0, 0.84
.;D;D;.;D;P;.;.
Vest4
0.90, 0.91, 0.83, 0.85, 0.96
MutPred
0.93
.;Loss of MoRF binding (P = 0.0176);Loss of MoRF binding (P = 0.0176);.;Loss of MoRF binding (P = 0.0176);Loss of MoRF binding (P = 0.0176);.;Loss of MoRF binding (P = 0.0176);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at